Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital

Infection, Genetics and Evolution

Volumn 36, Issue , 2015, Pages 1-7

  Selasi, Gati Noble ^a   Nicholas, Asiimwe ^a   Jeon, Hyejin ^a   Lee, Yoo Chul ^a   Yoo, Jeong Rae ^b   Heo, Sang Taek ^b   Lee, Je Chul ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

Author keywords

Carbapenem; Colistin; Pulsotype; Resistance; Sequence type

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; NETILMICIN; NUCLEOTIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYMYXIN B; SULBACTAM; TETRACYCLINE; TIGECYCLINE; TIMENTIN; TOBRAMYCIN; ACYLTRANSFERASE; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; CONTROLLED STUDY; DYNAMICS; GENE; GENE DELETION; GENE INSERTION; GENE SEQUENCE; KOREAN (PEOPLE); LPXA GENE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTIONS; CLASSIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; DRUG EFFECTS; GENETICS; GENOTYPE; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; MUTATION; PHENOTYPE; SOUTH KOREA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ACYLTRANSFERASES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; CROSS INFECTION; GENOTYPE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MUTATION; PHENOTYPE; REPUBLIC OF KOREA;

EID: 84940983576     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2015.09.001     Document Type: Article

References (33)

1. Badger J., Chie-Leon B., Logan C., Sridhar V., Sankaran B., Zwart P.H., Nienaber V. Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii. Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 2012, 68:1477-1481.
2. Bartual S.G., Seifert H., Hippler C., Luzon M.A., Wisplinghoff H., Rodríguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 2005, 43:4382-4390.
3. Beceiro A., Llobet E., Aranda J., Bengoechea J.A., Doumith M., Hornsey M., Dhanji H., Chart H., Bou G., Livermore D.M., Woodford N. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 2011, 55:3370-3379.
4. Bonnin R.A., Naas T., Poirel L., Nordmann P. Phenotypic, biochemical, and molecular techniques for detection of metallo-β-lactamase NDM in Acinetobacter baumannii. J. Clin. Microbiol. 2012, 50:1419-1421.
5. Chen S.J., Chao T.F., Chiang M.C., Kuo S.C., Chen L.Y., Chiang D.H., Yin T., Chen T.L., Fung C.P. Predictors of mortality in surgical patients with Acinetobacter baumannii bacteremia. J. Microbiol. Immunol. Infect. 2011, 44:209-214.
6. Cho Y.J., Moon D.C., Jin J.S., Choi C.H., Lee Y.C., Lee J.C. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn. Microbiol. Infect. Dis. 2009, 64:185-190.
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21 2011, CLSI, Wayne, PA.
8. Diancourt L., Passet V., Nemec A., Dijkshoorn L., Brisse S. The population structure of Acinetobacter baumannii: expanding multi-resistant clones from an ancestral susceptible genetic pool. PLoS One 2010, 5:e10034.
9. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5:939-951.
10. Falagas M.E., Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 2005, 40:1333-1341.
11. Gurung M., Rho J.S., Lee Y.C., Kim H.S., Moon S.Y., Yu B.H., Lee J.H., Jang C.W., Chung S.Y., Cho I.H., Jee H.S., Choi S.W., Heo J.Y., Lee J.C. Emergency and spread of carbapenem resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect. Genet. Evol. 2013, 19:219-222.
12. Héritier C., Poirel L., Lambert T., Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2005, 49:3198-3202.
13. Jeannot K., Diancourt L., Vaux S., Thouverez M., Ribeiro A., Coignard B., Courvalin P., Brisse S. Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France. PLoS One 2014, 9:e115452.
14. Jeon B.C., Jeong S.H., Bae I.K., Kwon S.B., Lee K., Young D., Lee J.H., Song J.S., Lee S.H. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J. Clin. Microbiol. 2005, 43:2241-2245.
15. Kamolvit W., Sidjabat H.E., Paterson D.L. Molecular epidemiology and mechanisms of carbapenem resistance of Acinetobacter spp. in Asia and Oceania. Microb. Drug Resist. 2015, 21:424-434.
16. Lee J.H., Choi C.H., Kang H.Y., Lee J.Y., Kim J., Lee Y.C., Seol S.Y., Cho D.T., Kim K.W., Song D.Y., Lee J.C. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genospecies 13TU. J. Antimicrob. Chemother. 2007, 59:633-639.
17. Lee Y., Lee J., Jeong S.H., Lee J., Bae I.K., Lee K. Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J. Antimicrob. Chemother. 2011, 66:66-72.
18. Lin Y.C., Hsia K.C., Chen Y.C., Sheng W.H., Chang S.C., Liao M.H., Li S.Y. Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob. Agents Chemother. 2010, 54:2078-2084.
19. Lu P.L., Liu Y.C., Toh H.S., Lee Y.L., Liu Y.M., Ho C.M., Huang C.C., Liu C.E., Ko W.C., Wang J.H., Tang H.J., Yu K.W., Chen Y.S., Chuang Y.C., Xu Y., Ni Y., Chen Y.H., Hsueh P.R. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int. J. Antimicrob. Agents 2012, 40:S37-S43. (Suppl.).
20. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., Paterson D.L., Rice L.B., Stelling J., Struelens M.J., Vatopoulos A., Weber J.T., Monnet D.L. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18:268-281.
21. Moffatt J.H., Harper M., Harrison P., Hale J.D., Vinogradov E., Seemann T., Henry R., Crane B., St Michael F., Cox A.D., Adler B., Nation R.L., Li J., Boyce J.D. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 2010, 54:4971-4977.
22. Mugnier P.D., Poirel L., Naas T., Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 2010, 16:35-40.
23. Nickel G.C., Bajaksouzian S., Lavender H., Murthy A.R., Jacobs M.R., Bonomo R.A. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 2009, 53:3628-3634.
24. Park Y.K., Lee G.H., Baek J.Y., Chung D.R., Peck K.R., Song J.H., Ko K.S. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea. Microb. Drug Resist. 2010, 16:143-149.
25. Park Y.K., Choi J.Y., Shin D., Ko K.S. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2011, 37:525-530.
26. Park Y.K., Jung S.I., Park K.H., Kim D.H., Choi J.Y., Kim S.H., Ko K.S. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7years. J. Med. Microbiol. 2012, 61:71-79.
27. Peleg A.Y., Potoski B.A., Rea R., Adams J., Sethi J., Capitano B., Husain S., Kwak E.J., Bhat S.V., Paterson D.L. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J. Antimicrob. Chemother. 2007, 59:128-131.
28. Pfizer Inc.(Wyeth Pharmaceuticals Inc.) Tygacil® Product Insert 2014, Pfizer Inc., Philadelphia, PA, (http://www.pfizerpro.com/hcp/tygacil).
29. Poirel L., Cabanne L., Vahaboglu H., Nordmann P. Genetic environment and expression of the extended-spectrum β-lactamase blaPER-1 gene in gram-negative bacteria. Antimicrob. Agents Chemother. 2005, 49:1708-1713.
30. Qi C., Malczynski M., Parker M., Scheetz M.H. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 2008, 46:1106-1109.
31. Valenza G., Seifert H., Decker-Burgard S., Laeuffer J., Morrissey I., Mutters R. Comparative activity of carbapenem testing (COMPACT) study in Germany. Int. J. Antimicrob. Agents 2012, 39:255-258. for the COMPACT Germany Study Group.
32. Yong D., Choi Y.S., Roh K.H., Kim C.K., Park Y.H., Yum J.H., Lee K., Chong Y. Increasing prevalence and diversity of metallo-β-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. Antimicrob. Agents Chemother. 2006, 50:1884-1886.
33. Yong D., Shin H.B., Kim Y.K., Cho J., Lee W.G., Ha G.Y., Choi T.Y., Jeong S.H., Lee K., Chong Y., KONSAR group Increase in the prevalence of carbapenem-resistant Acinetobacter isolates and ampicillin-resistant non-typhoidal Salmonella species in Korea: a KONSAR study conducted in 2011. Infect. Chemother. 2014, 46:84-93.